Literature DB >> 20803521

Opioid-modulating properties of the neuropeptide FF system.

Lionel Moulédous1, Catherine Mollereau, Jean-Marie Zajac.   

Abstract

Opioid receptors are involved in the control of pain perception in the central nervous system together with endogenous neuropeptides, termed opioid-modulating peptides, participating in a homeostatic system. Neuropeptide FF (NPFF) and related peptides possess anti-opioid properties, the cellular mechanisms of which are still unclear. The purpose of this review is to detail the phenomenon of cross-talk taking place between opioid and NPFF systems at the in vivo pharmacological level and to propose cellular and molecular models of functioning. A better knowledge of the mechanisms underlying opioid-modulating properties of NPFF has potential therapeutic interest for the control of opioid functions, notably for alleviating pain and/or for the treatment of opioid abuse.
Copyright © 2010 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20803521     DOI: 10.1002/biof.116

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  17 in total

1.  Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists.

Authors:  Thuy Nguyen; Ann M Decker; Tiffany L Langston; Kelly M Mathews; Justin N Siemian; Jun-Xu Li; Danni L Harris; Scott P Runyon; Yanan Zhang
Journal:  ACS Chem Neurosci       Date:  2017-08-09       Impact factor: 4.418

2.  The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ- and κ-opioid receptors.

Authors:  Biao Xu; Mengna Zhang; Xuerui Shi; Run Zhang; Dan Chen; Yong Chen; Zilong Wang; Yu Qiu; Ting Zhang; Kangtai Xu; Xiaoyu Zhang; Wolfgang Liedtke; Rui Wang; Quan Fang
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

3.  GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.

Authors:  Lionel Moulédous; Carine Froment; Stéphanie Dauvillier; Odile Burlet-Schiltz; Jean-Marie Zajac; Catherine Mollereau
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

4.  Heterologous regulation of Mu-opioid (MOP) receptor mobility in the membrane of SH-SY5Y cells.

Authors:  Kévin Carayon; Lionel Moulédous; Anne Combedazou; Serge Mazères; Evert Haanappel; Laurence Salomé; Catherine Mollereau
Journal:  J Biol Chem       Date:  2014-09-02       Impact factor: 5.157

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 6.  Nonpeptide ligands of neuropeptide FF: current status and structural insights.

Authors:  Jessica V Mankus; Christopher R McCurdy
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

7.  BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.

Authors:  Ning Li; Zheng-Lan Han; Zi-Long Wang; Yan-Hong Xing; Yu-Long Sun; Xu-Hui Li; Jing-Jing Song; Ting Zhang; Run Zhang; Meng-Na Zhang; Biao Xu; Quan Fang; Rui Wang
Journal:  Br J Pharmacol       Date:  2016-04-21       Impact factor: 8.739

8.  Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

Authors:  K Elhabazi; J M Trigo; C Mollereau; L Moulédous; J-M Zajac; F Bihel; M Schmitt; J J Bourguignon; H Meziane; B Petit-demoulière; F Bockel; R Maldonado; F Simonin
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

9.  Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord.

Authors:  Lydia K Miller; Xiaowen Hou; Ramona M Rodriguiz; Khatuna Gagnidze; Jonathan V Sweedler; William C Wetsel; Lakshmi A Devi
Journal:  J Neurochem       Date:  2011-11-01       Impact factor: 5.372

10.  Development, sex steroid regulation, and phenotypic characterization of RFamide-related peptide (Rfrp) gene expression and RFamide receptors in the mouse hypothalamus.

Authors:  Matthew C Poling; Joshua Kim; Sangeeta Dhamija; Alexander S Kauffman
Journal:  Endocrinology       Date:  2012-02-21       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.